Tag

Tag: Heptares Therapeutics

biotech news bayer

09/08/2019 3 mins

More News! Lynparza strikes again, the avocado genome sequenced, the TARDIS, and more…

Heptares Orexia Inexia Narcolepsy

06/02/2019 2 mins

British Biotech Spin-Offs Get €40M Funding to Treat Narcolepsy

10/01/2018 2 mins

Heptares and Imperial College London Will Tackle Diseases of the Gastrointestinal Tract

05/10/2017 1 min

British Biotech Founder Receives the Nobel Prize in Chemistry 2017

01/09/2017 1 min

Allergan Takes to the Clinic a New Alzheimer’s Drug from a €3Bn Deal

17/07/2017 6 mins

Pinning Down Elusive Targets: Interviewing the Co-Founder & CSO of Heptares

30/06/2017 1 min

More News! Roche’s Stellar Hemophilia A Treatment & Two Big Rounds for Arix

06/06/2017 6 mins

A Painful Case: How Biotech is trying to Break Through in Analgesia

18/05/2017 1 min

Heptares receives €4.5M Milestone for New Migraine Drug Candidate

27/04/2017 1 min

Heptares Finds New GPCR Target to Treat Pain, Cancer and Inflammation

checkpoint inhibitors ose immunotherapeutics cancer cells

05/04/2017 2 mins

Heptares Takes Home €11M for its Next-Generation Checkpoint Inhibitor

17/03/2017 1 min

More News! Allergan sees Patient Deaths, New Alzheimer’s Targets?

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and its' freely accessible content.